VORICONAZOLE (Alvogen Inc.)
Welcome to the PulseAid listing for the VORICONAZOLE drug offered from Alvogen Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | VORICONAZOLE |
| SUBSTANCE NAME: | VORICONAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-08-08 |
| END MARKETING DATE: | 0000-00-00 |
VORICONAZOLE HUMAN PRESCRIPTION DRUG Details:
| Item Description | VORICONAZOLE from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2016-08-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-466_ba83c484-7ae1-6895-bc38-7c693c0db6ed |
| PRODUCT NDC: | 47781-466 |
| APPLICATION NUMBER: | ANDA206398 |
Other VORICONAZOLE Pharmaceutical Manufacturers / Labelers:
